
During IVF, the scan before embryo transfer checks more than the ovaries. It also measures the lining of the womb, called the endometrium. When the report says thin endometrium, many people worry that the transfer will be cancelled or that pregnancy is no longer possible. Neither is automatically true. This guide explains what lining thickness means, how it is measured, why it can stay thin, and which treatments are supported by guidance from the European Society of Human Reproduction and Embryology (ESHRE) and the UK Human Fertilisation and Embryology Authority (HFEA). It is general information; your own doctor reads your scans in the context of your history.
The short answer
A lining of about 7 mm or less on ultrasound is commonly called thin. Research links a thin lining with lower pregnancy chances on average, but a thin endometrium alone does not predict the outcome for any one person, and pregnancies do happen with thinner linings. Doctors usually look for a reason, such as low oestrogen exposure or scar tissue inside the womb, and adjust the preparation for transfer. ESHRE does not recommend several popular add-ons for a thin lining, including platelet-rich plasma (PRP) and G-CSF infusions, outside research settings.
What is the endometrium, and how is its thickness measured?
The endometrium is the inner lining of the uterus. In each menstrual cycle it grows under the influence of oestrogen, matures under progesterone, and is shed as a period if no pregnancy occurs. An embryo has to attach to this lining to implant, so its condition is checked before an embryo transfer.
Thickness is measured with a transvaginal ultrasound scan, from one side of the lining to the other at its thickest point, and reported in millimetres. In a fresh IVF cycle it is usually measured around the time of the trigger injection; in a frozen embryo transfer it is checked before progesterone is started. The scan also shows the pattern of the lining. A "triple-line" or trilaminar pattern looks like three bright lines with darker bands between them.
What counts as a thin endometrium?
There is no single agreed definition, but 7 mm is the cut-off used most often in research. A systematic review in Human Reproduction Update, covering 22 studies and more than 10,000 IVF cycles, found that a lining of 7 mm or less was uncommon: it was seen in only 2.4% of cycles. Some clinics use 8 mm as their own working threshold. Your clinic will tell you which value it uses and why.
Why lining thickness matters in IVF
Studies consistently show that, on average, pregnancy chances are lower when the lining is thin. The figures below come from published research in other countries. They are not MOM IVF data, and they describe groups of patients, not what will happen to you.
| Study | What was studied | Main finding |
|---|---|---|
| Kasius et al., Human Reproduction Update (2014) | 22 studies; 10,724 IVF cycles | Clinical pregnancy was about 23% with a lining of 7 mm or less versus about 48% above 7 mm. The authors concluded that thickness alone has limited ability to identify women with a low chance of pregnancy. |
| Reproductive Biology and Endocrinology (2026) | 16,566 frozen single blastocyst transfers at one centre | A lining of 7 mm or less was linked with lower odds of live birth and higher odds of miscarriage and preterm birth, compared with 8 to 9 mm. The authors noted that a thin lining alone may not warrant cancelling a transfer. |
| Fertility and Sterility (2026) | 45,729 fresh and frozen transfers | The link between thickness and live birth was not a straight line: it was steepest at lower thicknesses and levelled off at around 9 to 10 mm in frozen cycles. A triple-line pattern was linked with better outcomes, especially in thinner linings. |
Thickness is one signal, not a verdict
Because a thin lining is uncommon and because many other factors matter, such as the embryo, age and the reason for infertility, researchers caution against using thickness alone to cancel a cycle or stop treatment. The 2014 review stated that using lining thickness to decide on cycle cancellation, freezing all embryos or refraining from further IVF "seems not to be justified" on that evidence alone. In practice, your doctor weighs the measurement together with the pattern on the scan, your previous cycles and the embryos available.
Common reasons the lining stays thin
A thin lining is a finding, not a diagnosis. Doctors usually try to understand why it is thin, because the reason guides what can be done. Common possibilities include:
- Not enough oestrogen effect. The lining grows in response to oestrogen. A low dose, poor absorption of tablets, or a natural cycle with low hormone levels can leave it thinner than expected.
- Scar tissue inside the womb (intrauterine adhesions). Scarring after procedures on the lining, such as a D&C, or after some infections can stop parts of the lining from growing. When adhesions are significant, the condition is called Asherman syndrome.
- Inflammation of the lining. Chronic endometritis, a low-grade inflammation, is one of the conditions ESHRE suggests can be assessed when embryos repeatedly fail to implant.
- Other uterine conditions. Polyps, fibroids that distort the cavity, or a uterine septum can affect how the lining develops and how it looks on a scan.
- No clear cause. Sometimes no reason is found, and the lining is simply thinner in some cycles than others.
How doctors assess a thin lining
Repeat scans and a review of the preparation
The first step is often a repeat scan, sometimes after a few more days of oestrogen, and a review of how the lining was prepared. ESHRE good practice recommendations on recurrent implantation failure recommend re-assessing endometrial thickness and reviewing the oestrogen treatment regimen if the lining remains thin. Your doctor may also review your hormone tests and medical history; our fertility assessment page explains the tests usually involved.
Hysteroscopy
If the lining stays thin despite changes to the preparation, ESHRE notes that hysteroscopy can be considered to rule out adhesions or Asherman syndrome. A hysteroscopy uses a thin telescope passed through the cervix to look directly inside the womb, and some problems, such as polyps or adhesions, can be treated during the same procedure. You can read more about hysteroscopy and laparoscopy on our fertility treatment page.
Treatment options: what the evidence supports
Adjusting oestrogen preparation
According to ESHRE, making sure the lining has enough exposure to oestrogen remains the mainstay of management when a thin endometrium is found. This may mean a change in dose, a longer preparation phase, or adding oestrogen patches or vaginal tablets to oral tablets. The exact plan depends on your cycle and your doctor's assessment, so do not change any medicine on your own.
Treating a cause inside the womb
When a scan or hysteroscopy shows adhesions, polyps or a septum, these can often be treated surgically, usually by hysteroscopy. ESHRE notes that these are established procedures, although their effect on pregnancy rates has not been well studied in every group of patients. If chronic endometritis is diagnosed, ESHRE states that antibiotic treatment can be considered.
Freezing embryos and planning a later transfer
If the lining is not ready in a fresh cycle, some doctors suggest freezing the embryos and transferring one in a later, separately prepared cycle. This gives time to adjust the preparation without affecting the embryos, which are stored by vitrification. Whether this is right for you is a clinical decision. Information about storage is on our embryo preservation page, and our step-by-step IVF process guide shows where transfer fits in the overall treatment.
Add-ons with uncertain evidence
Many treatments are promoted online for a thin lining. Two expert bodies have reviewed the main ones. Their current positions are summarised below.
| Add-on | ESHRE good practice recommendations (2023) | HFEA rating |
|---|---|---|
| Intrauterine platelet-rich plasma (PRP) | Not recommended: low-quality evidence and no safety data on embryo exposure. | Red for thin or refractory endometrium (potential safety concerns, no moderate or high-quality evidence of benefit). |
| Intrauterine G-CSF infusion | Not recommended: evidence inconclusive, small studies. | Not on the HFEA add-ons list. |
| Endometrial scratching | Not recommended for routine use. | Amber for most IVF and ICSI patients (conflicting evidence). |
| Stem cell therapy for thin endometrium | Not recommended: unclear rationale and serious safety concerns. | Not on the HFEA add-ons list. |
A 2026 meta-analysis of seven small randomised trials in Frontiers in Endocrinology found that intrauterine PRP increased lining thickness by just under 1 mm on average, but the certainty of evidence for pregnancy outcomes was very low, and the authors called the findings preliminary. If an add-on is suggested to you, it is reasonable to ask what evidence supports it for your situation, what the risks are, and whether it is being offered as part of a study.
Key takeaways
- About 7 mm is the most common cut-off for a thin lining, but definitions vary between clinics.
- A thin lining lowers average pregnancy chances in studies, yet it does not decide the outcome for any one person.
- Finding the reason, such as low oestrogen effect or scar tissue, matters more than the number alone.
- Adjusting oestrogen and treating problems inside the womb are the approaches with guideline support; PRP, G-CSF and stem cells are not recommended outside research.
Can diet or lifestyle make the lining thicker?
Searches for how to increase endometrial thickness often lead to lists of foods, herbs and supplements. None of the guidelines cited in this article recommends any particular food or supplement to thicken the lining, and some products sold for this purpose have not been tested in good-quality trials. General health still matters for fertility: a healthy weight, not smoking, limiting alcohol and managing conditions such as thyroid disease all support treatment. Our article on lifestyle factors and reproductive health covers these in more detail. Always tell your doctor about any supplement before taking it during treatment.
Questions to ask your doctor
- What thickness does the clinic use as its working threshold for transfer, and what was my measurement and pattern?
- Is there a likely reason for my thin lining, and do I need any further tests, such as a hysteroscopy?
- How will my oestrogen preparation change in the next cycle?
- Would freezing embryos and transferring in a later cycle be sensible in my case?
- If an add-on is suggested, what is the evidence and what are the risks?
If you are preparing for a transfer, our guide on what happens after embryo transfer explains the days that follow.
Talk to us
If your scan report mentions a thin lining, or you would like your previous cycles reviewed before the next transfer, our team can go through your reports with you.
To book a consultation, call +91 98986 83636 (Monday to Saturday, 11 AM to 3 PM) or use the appointment form.
MOM IVF Fertility & Research Center Pvt. Ltd., 12-2-710, 1st & 2nd Floors, Beside Premier Hospital, Nanal Nagar X Roads, Mehdipatnam, Hyderabad, Telangana 500028.
Sources
- Kasius A, et al. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Human Reproduction Update, 2014.
- How endometrial thickness affects pregnancy and perinatal outcomes: a retrospective study of 16,566 frozen-thawed single blastocyst transfer cycles. Reproductive Biology and Endocrinology, 2026.
- Joint associations of endometrial thickness and pattern with live birth after fresh and frozen-thawed embryo transfer: a retrospective cohort study of 45,729 cycles. Fertility and Sterility, 2026.
- ESHRE Add-ons Working Group. Good practice recommendations on add-ons in reproductive medicine. Human Reproduction, 2023.
- ESHRE Working Group on Recurrent Implantation Failure. ESHRE good practice recommendations on recurrent implantation failure. Human Reproduction Open, 2023.
- HFEA. Platelet-rich plasma (PRP) and Endometrial scratching add-on ratings.
- Efficacy of platelet-rich plasma or plasma rich in growth factors in the treatment of thin endometrium: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology, 2026.
This article is general health information and is not a substitute for a consultation. Treatment decisions depend on individual tests and medical history. Research figures quoted here come from published studies and are not MOM IVF results.


